Skip to main content Accessibility help

Platelet Monoamine Oxidase in Schizophrenia and Manic-Depressive Illness

  • Robert H. Belmaker (a1), Kirsten Ebbesen (a1), Richard Ebstein (a1) and Ranan Rimon (a1)


Monoamine oxidase (MAO) is an important enzyme in the catabolism of brain biogenic amines. Platelet MAO has been reported to be moderately reduced in manic-depressive patients and markedly reduced in schizophrenic patients. This enzyme's activity has been shown to be under a large degree of genetic control and has been proposed as a ‘genetic marker’ in schizophrenia. A transcultural replication of the finding of low platelet MAO in schizophrenia and manic-depressive illness was carried out at the Jerusalem Mental Health Centre. Manic-depressive patients were found to have higher platelet MAO activity than schizophrenic patients, as reported previously, but control individuals were as low as the schizophrenic patients. It is unlikely that platelet MAO activity is a transculturally-valid marker for schizophrenia.


Corresponding author

Requests for reprints should be addressed to Dr Belmaker.


Hide All
1. Kopin, I. J. (1964) Storage and metabolism of catecholamines: The role of monoamine oxidase. Pharmac. Rev., 16, 179.
2. Murphy, D. L., Belmaker, R. & Wyatt, R. J. (1974) Monoamine oxidase in schizophrenia and other behavioral disorders. J. psychiat. Res., 11, 221.
3. Nies, A., Robinson, D. S., Lamborn, K. R. & Lammpert, R. P. (1973) Genetic control of platelet and plasma monoamine oxidase activity. Arch. gen. Psychiat., 28, 834.
4. Murphy, D. L. & Wyatt, R. J. (1972) Reduced MAO activity in blood platelets from schizophrenic patients. Nature, 239, 225.
5. Murphy, D. L. & Weiss, R. (1972) Reduced monoamine oxidase activity in blood platelets from bipolar depressed patients. Amer. J. Psychiat., 128, 11.
6. Wyatt, R. J., Murphy, D. L., Belmaker, R., Cohen, S., Donnelly, G. H. & Pollin, W. (1973) Reduced monoamine oxidase in platelets: A possible genetic marker for vulnerability to schizophrenia. Science, 179, 916.
7. Meltzer, H. Y. & Stahl, S. M. (1974) Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients. Res. Comm. in Chem. Path, and Pharmacol., 7, 419.
8. Carpenter, W. T. Jr., Murphy, D. L. & Wyatt, R.J. (1975) Platelet monoamine oxidase activity in acute schizophrenia. Amer. J. Psychiat., 132, 438.
9. Friedman, E., Shopsin, B., Sathananthan, G. & Gershon, S. (1974) Blood platelet monoamine oxidase activity in psychiatric patients. Amer. J. Psychiat., 131, 1392.
10. Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A. Jr., Winokur, G. & Munoz, R. (1972) Diagnostic criteria for use in psychiatric research. Arch. gen. Psychiat., 26, 5763.
11. Murphy, D. L., Donnelly, C. H., Belmaker, R., Carlson, H., Baker, M. & Wyatt, R. J. Influence of age, sex and some drugs and hormones on human platelet monoamine oxidase activity. In preparation.
12. Brecher, G. & Cronkite, E. P. (1950) Morphology and enumeration of human blood platelets. J. appl. Physiol., 3, 365.
13. Wurtman, R. J. & Axelrod, J. (1963) A sensitive and specific assay for the estimation of monoamine oxidase. Biochem. Pharmac., 12, 1439.
14. Robinson, D. S., Lovenberg, W., Keiser, H. & Sjoerdsma, J. (1968) Effects of drugs on human blood platelet and plasma amine oxidase activity in vitr. and in vivo. Biochem. Pharmac., 17, 109.
15. Lowry, O. H., Rosenbrough, M. J., Farr, A. L. & Randall, R. J. (1951) Protein measurement with the folin phenol reagent. J. biol. Chem., 193, 265.
16. Murphy, D. L. Personal communications.
17. Bockar, J., Roth, R. & Heninger, G. R., (1975) Increased platelet monoamine oxidase activity during lithium carbonate therapy. Life Science. 15, 2109.
18. Sandler, M., Carter, S. B., Cuthbert, M. F. & Pare, C. M. B. (1975) Is there an increase in monoamine-oxidase activity in depressive illness? Lancet, i, 1045.
19. Goodwin, F. K., Murphy, D. L., Dunner, D. L. & Bunney, W. E. (1972) Lithium response in unipolar versus bipolar depression. Amer. J. Psychiat., 129, 76.
20. Robinson, D. S., Davis, J. M., Nies, A., Ravaris, G. L. & Sylwester, D. (1971) Relation of sex and aging to monoamine oxidase activity of human brain, plasma and platelets. Arch. gen. Psychiat., 24, 536.
21. Schwartz, M., Aikens, A. M. & Wyatt, R. J. (1974) Monoamine oxidase in brains from schizophrenic and mentally normal individuals. Psychopharmacologia, 38, 319.
22. Domino, E. F., Krause, R. R. & Bowers, J. (1973) Various enzymes involved with putative transmitters. Arch. gen. Psychiat., 29, 195.
23. Wise, C. D., Baden, M. M. & Stein, L. (1974) Postmortem measurement of enzymes in human brain: Evidence of a central noradrenergic deficit in schizophrenia. J. psychiat. Res., 11, 185.
24. Youdim, M. B. H. (1973) Multiple forms of mitochondrial monoamine oxidase. Brit. med. Bull., 29, 120.
25. Collins, G. G. S. & Sandler, M. (1971) Human blood platelet monoamine oxidase. Biochem. Pharmac., 20, 289.
26. Houslay, M. D. & Tipton, K. F. (1973) The nature of the electrophoretically separable multiple forms of rat liver monoamine oxidase. Bioehem. J., 135, 173.
27. Yoshida, A. (1973) Hemolytic anemia and G6PD deficiency. Science, 179, 532.
28. Rosenthal, D. (1972) Genetic Theory and Abnormal Behavior. New York: McGraw-Hill.


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Platelet Monoamine Oxidase in Schizophrenia and Manic-Depressive Illness

  • Robert H. Belmaker (a1), Kirsten Ebbesen (a1), Richard Ebstein (a1) and Ranan Rimon (a1)
Submit a response


No eLetters have been published for this article.


Reply to: Submit a response

Your details

Conflicting interests

Do you have any conflicting interests? *